Make A Forward-looking Plan With High-yielding Investments
Total Reports: 83
Analysts view the syphilis immunoassay diagnostics market as a dynamic and growing sector, primarily driven by the rising prevalence of syphilis cases globally and increased awareness surrounding sexually transmitted infections (STIs).
Rep Id : TMRGL2140 | Published | Healthcare | November 2024
Increase in incidence of lung cancer, especially in developing countries, is the key driver of the global lung cancer diagnostics market. Surge in awareness about the importance of early and accurate diagnosis of this cancer is expected to accelerate industry development.
Rep Id : TMRGL74159 | Published | Healthcare | October 2024
Growth in demand for personalized medicine, surge in prevalence of chronic diseases, increase in use of metabolomics approaches in drug discovery, rise in investments in R&D activities, and advent of innovative analytical instruments and software are driving the metabolomics market growth.
Rep Id : TMRGL903 | Published | Healthcare | June 2024
Colon cancer, which is caused by cancer of the colon and rectum, ranks third in worldwide mortality charts according to the World Health Organization (WHO).
Rep Id : TMRGL3698 | Published | Healthcare | June 2024
The large number of surgical procedures conducted globally is expected to bolster the hemostasis products market growth as a practical solution related to blood management.
Rep Id : TMRGL13880 | Published | Healthcare | June 2024
Increase in prevalence and incidence of sexually transmitted diseases (STDS) globally is anticipated to be a key driver of the market. STD is predominant in lower and middle income countries and hence governments have been taken up various awareness programs and activities related to prevention and spread of STDs.
Rep Id : TMRGL1207 | Published | Healthcare | May 2024
Increase in demand for targeted medicines is propelling the companion diagnostic tests in oncology market size. Companion diagnostics play a significant role in the development of targeted drugs for cancer treatment.
Rep Id : TMRGL4684 | Published | Healthcare | April 2024
Rise in prevalence of pneumonia and legionella-related illnesses and rapid advancements in legionella testing are fostering the legionella testing market size. Legionella testing is used to detect the presence of legionella bacteria, which can cause a severe form of pneumonia known as legionnaires’ disease. Rise in prevalence of community-acquired pneumonia
Rep Id : TMRGL3980 | Published | Healthcare | April 2024
Rise in prevalence of mycoplasmal infections is fueling the mycoplasma diagnostics market size. A common result of mycoplasma infection is pneumonia. Mycoplasma pneumonia is a common cause of community-acquired pneumonia.
Rep Id : TMRGL1677 | Published | Healthcare | April 2024
Rise in prevalence of targeted diseases is the primary factor responsible for the global CT scanners market growth. Computed tomography scanners combine x-ray images taken from various angles around the body and use computer processing to create cross-sectional images of soft tissues, blood vessels, and bones.
Rep Id : TMRGL852 | Published | Healthcare | March 2024
Increase in preference for cellular assays in basic research and drug discovery applications is a primary factor driving the cell based assays market size. Cell based assays help understand the functionality of a peculiar cell type in conditions such as inflammation.
Rep Id : TMRGL846 | Published | Healthcare | March 2024
Increase in prevalence of chronic and infectious diseases, the need for advanced diagnostic tools, and technological advancements, are fueling the in vitro diagnostics (IVD) market size. Furthermore, the demand for accurate and efficient diagnostics is expected to drive market progress.
Rep Id : TMRGL1395 | Published | Healthcare | March 2024
The biomarkers market covers a broad range of measurable signals, such as genetic variances, protein levels, and biochemical alterations, which indicate biological functions, disease conditions, or responses to therapies. Biomarkers have a critical role across various sectors, including diagnostics, drug exploration, personalized medicine, and clinical studies.
Rep Id : TMRGL520 | Published | Healthcare | February 2024
Helicobacter pylori (H. pylori) is a spiral-shaped gram-negative aerobic bacterium that infects the stomach. When H. pylori infects the stomach lining, it results in stomach infections.
Rep Id : TMRGL45312 | Published | Healthcare | February 2024
Radiation dose is the amount of energy from radiation that is actually absorbed by the body. It is important to monitor and track the amount of radiation dose injected into the body while conducting a medical procedure. Excessive dosage can create a hazardous impact on patients and also affect the
Rep Id : TMRGL25394 | Published | Healthcare | December 2023
Sterility testing refers to a set of activities performed to confirm that products are free from microorganisms. The sterility testing method involves passing a quantity of drug product through filters designed to retain microorganisms. It is followed by a rinse to ensure that no drug product remains on the filter,
Rep Id : TMRGL23714 | Published | Healthcare | December 2023
Gastrointestinal (GI) pathogen testing is a diagnostic approach used to identify the specific microorganisms causing a gastrointestinal (GI) infection. These infections can be caused by various pathogens, including bacteria, viruses, and parasites, each with its own unique characteristics and treatment options.
Rep Id : TMRGL85890 | Published | Healthcare | December 2023
Cervical dysplasia refers to abnormal changes in the cells on the surface of the cervix. The changes are not cancer, but can lead to cancer of the cervix if not treated.
Rep Id : TMRGL2241 | Published | Healthcare | November 2023
Imaging contrast agents are chemicals used in medical imaging procedures, such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, to improve the visibility of internal organs or structures in the human body.
Rep Id : TMRGL876 | Published | Healthcare | November 2023
Integration of Artificial Intelligence (AI) in the field of cancer diagnostics marks a leap forward in the quest to enhance early detection, accurate diagnosis, and personalized treatment of cancer. AI, with its ability to analyze massive volumes of complex medical data and extract insights, is revolutionizing the landscape of cancer
Rep Id : TMRGL85783 | Published | Healthcare | August 2023
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
